Several parameters – such as tumor PD-L1 expression [3], tumor mutational burden [4, 5], or microsatellite instability [6] – have been proposed, but the identification of responders remains incomplete and requires access to tumor tissue [7, 8]. This evidence concerns the gene CD274 and neoplasm.